189 related articles for article (PubMed ID: 24077924)
1. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
Salgia RJ; Goodrich NP; Marrero JA; Volk ML
Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
[TBL] [Abstract][Full Text] [Related]
2. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
[TBL] [Abstract][Full Text] [Related]
3. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
[TBL] [Abstract][Full Text] [Related]
4. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.
Dumitra S; Alabbad SI; Barkun JS; Dumitra TC; Coutsinos D; Metrakos PP; Hassanain M; Paraskevas S; Chaudhury P; Tchervenkov JI
HPB (Oxford); 2013 Sep; 15(9):724-31. PubMed ID: 23490176
[TBL] [Abstract][Full Text] [Related]
6. Recipient obesity does not affect survival after deceased donor liver transplantation for hepatocellular carcinoma. A national retrospective cohort study in the United States.
Ata N; Ayloo S; Tsung A; Molinari M
HPB (Oxford); 2019 Jan; 21(1):67-76. PubMed ID: 30691592
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
9. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
11. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K; Ioannou GN
Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
[TBL] [Abstract][Full Text] [Related]
13. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
17. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
[TBL] [Abstract][Full Text] [Related]
18. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
[TBL] [Abstract][Full Text] [Related]
19. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]